Article
Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.
Molecular cancer therapeutics - 1 Feb 2010
Zhang Ping, Singh Anju, Yegnasubramanian Srinivasan, Esopi David, Kombairaju Ponvijay, Bodas Manish, Wu Hailong, Bova Steven G, Biswal Shyam
Abstract excerpt
Loss-of-function mutations in the nuclear factor erythroid-2-related factor 2 (Nrf2) inhibitor Kelch-like ECH-associated protein 1 (Keap1) result in increased Nrf2 activity in non-small cell lung cancer and confer therapeutic resistance. We detected point mutations in Keap1 gene, leading to nonconservative amino acid substitutions in prostate cancer cells. We found novel transcriptional and posttranscriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
